IMARC Group's report titled "Asia Pacific Biopsy Devices Market Report by Procedure Type (Surgical Biopsy, Needle Biopsy), Product (Biopsy Guidance Systems, Needle Based Biopsy Guns, Biopsy Needles, Biopsy Forceps, and Others), Application (Breast Biopsy, Lung Biopsy, Colorectal Biopsy, Prostate Biopsy, and Others), Guidance Technique (Ultrasound-guided Biopsy, Stereotactic-guided Biopsy, MRI-guided Biopsy, and Others), End User (Hospitals and Clinics, Academic and Research Institutes, and Others), and Country 2024-2032" The Asia Pacific biopsy devices market size reached US$ 410.5 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 821.3 Million by 2032, exhibiting a growth rate (CAGR) of 7.77% during 2024-2032.
Emerging trends in the Asia Pacific biopsy devices market include the adoption of minimally invasive biopsy techniques, which offer advantages such as reduced pain, minimal scarring, and quicker recovery times compared to traditional surgical biopsies. In addition to this, the utilization of less invasive procedures is enhancing patient comfort and acceptance, thereby increasing the demand for advanced biopsy devices. Furthermore, the advancement in technology in biopsy devices, such as vacuum-assisted biopsies and image-guided biopsy systems, is improving the accuracy and efficiency of the process, which is creating a positive outlook for the market. Besides this, the elevating use of personalized medicine, where biopsy devices play a key role in obtaining tissue samples for molecular and genetic analysis, enabling targeted cancer therapies, is expected to drive the Asia Pacific biopsy devices market over the forecasted period.
Grab a sample PDF of this report: https://www.imarcgroup.com/asia-pacific-biopsy-devices-market/requestsample
Asia Pacific Biopsy Devices Market Trends and Drivers:
Emerging trends in the Asia Pacific biopsy devices market include the adoption of minimally invasive biopsy techniques, which offer advantages such as reduced pain, minimal scarring, and quicker recovery times compared to traditional surgical biopsies. In addition to this, the utilization of less invasive procedures is enhancing patient comfort and acceptance, thereby increasing the demand for advanced biopsy devices. Furthermore, the advancement in technology in biopsy devices, such as vacuum-assisted biopsies and image-guided biopsy systems, is improving the accuracy and efficiency of the process, which is creating a positive outlook for the market. Besides this, the elevating use of personalized medicine, where biopsy devices play a key role in obtaining tissue samples for molecular and genetic analysis, enabling targeted cancer therapies, is expected to drive the Asia Pacific biopsy devices market over the forecasted period.
Report Segmentation:
The report has segmented the market into the following categories:
Breakup by Procedure Type:
- Surgical Biopsy
- Needle Biopsy
Breakup by Product:
- Biopsy Guidance Systems
- Needle Based Biopsy Guns
- Biopsy Needles
- Biopsy Forceps
- Others
Breakup by Application:
- Breast Biopsy
- Lung Biopsy
- Colorectal Biopsy
- Prostate Biopsy
- Others
Breakup by Guidance Technique:
- Ultrasound-guided Biopsy
- Stereotactic-guided Biopsy
- MRI-guided Biopsy
- Others
Breakup by End User:
- Hospitals and Clinics
- Academic and Research Institutes
- Others
Breakup by Country:
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.
About Us
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.
Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.
Contact US
IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
United States: +1-631-791-1145
